A Dose-Response Relationship to Radiotherapy for Cutaneous Lesions of Langerhans Cell Histiocytosis
Langerhans cell histiocytosis (LCH) is a rare disease, afflicting approximately 4.6 and 1-2 per 1 million children and adults, respectively. While LCH can involve numerous organ systems such as the lung or bone, it is uncommon for the disease to be limited to the skin. Radiotherapy has an establishe...
Saved in:
Main Authors: | Mark K. Farrugia, Carl Morrison, Francisco Hernandez-Ilizaliturri, Saif Aljabab |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2021/6680635 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Langerhans Cell Histiocytosis of the Cranial Base: Is Low-Dose Radiotherapy Effective?
by: Andreas Meyer, et al.
Published: (2012-01-01) -
Topical Imiquimod for the Treatment of Relapsed Cutaneous Langerhans Cell Histiocytosis after Chemotherapy in an Elderly Patient
by: Shinsaku Imashuku, et al.
Published: (2018-01-01) -
A Rare Case of Erdheim-Chester Disease (Non-Langerhans Cell Histiocytosis) with Concurrent Langerhans Cell Histiocytosis: A Diagnostic and Therapeutic Challenge
by: Hamza Hashmi, et al.
Published: (2018-01-01) -
Rare Lung Diseases III: Pulmonary Langerhans’ Cell Histiocytosis
by: Stephen C Juvet, et al.
Published: (2010-01-01) -
An Aggressive Form of Langerhan Cell Histiocytosis in an Adult: Therapeutic Challenges
by: Karan Seegobin, et al.
Published: (2017-01-01)